SynapDx Raises $15.4 Million for Earlier Autism Diagnosis

7-22-2013 11-29-33 PM

Lexington, MA-based startup SynapDx raises $15.4 million in new funding led by Google Ventures. Foundation Medical Partners, North Bridge Venture Partners, and General Catalyst Partners have also contributed to the investment round.

SynapDx, a diagnostics company, is developing a blood test for early detection of autism. The company is working at the intersection of big data, genomics, and informatics as it pores through data from children with autism in search of a reliable marker of the condition.

“The best diagnostic tests of our era will be developed at the nexus of advanced genomics and cutting edge informatics. SynapDx stands to revolutionize the autism field while building the pediatric genomics company. Given my prior involvement on Autism Speaks’ board, I am well aware of the need for better diagnostics to help clinicians and families get children identified as quickly as possible.” – Andrew Conrad, PhD, Google Ventures.

In addition to the funding, SynapDx will add Google’s Andrew Conrad, PhD to its board of directors. Conrad is the former chief scientific officer at LabCorp and the co-founder of the National Genetics Institute.

↑ Back to top

Founding Sponsors

Platinum Sponsors